ZeOmega Revenue and Competitors

Dallas, TX USA

Location

$21.5M

Total Funding

Estimated Revenue & Valuation

  • ZeOmega's estimated annual revenue is currently $120.8M per year.(i)
  • ZeOmega's estimated revenue per employee is $184,150
  • ZeOmega's total funding is $21.5M.

Employee Data

  • ZeOmega has 656 Employees.(i)
  • ZeOmega grew their employee count by 5% last year.

ZeOmega's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Associate VP, Interoperability StrategyReveal Email/Phone
3
Associate VP Cloud Infrastructure & Information SystemsReveal Email/Phone
4
Regional VP, Sales/ Business DevelopmentReveal Email/Phone
5
Associate VP, Client SuccessReveal Email/Phone
6
Co-Founder and VP, Product DevelopmentReveal Email/Phone
7
Regional VP Population Health ManagementReveal Email/Phone
8
Co-Founder, VP Quality MgmtReveal Email/Phone
9
VP Clinical Support ServicesReveal Email/Phone
10
VP, Product PlanningReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.3M59N/AN/AN/A
#2
$16612M829777%N/AN/A
#3
$104.9M5903%$29.5MN/A
#4
$1.8M25-4%$7.3MN/A
#5
$8.1M64N/AN/AN/A
#6
$435.8M1153N/AN/AN/A
#7
$34.5M229-25%$259M$1B
#8
$908.3M4634N/AN/AN/A
#9
$14.1M101-10%N/AN/A
#10
$277.1M733N/AN/AN/A
#11
$271.7M1357-14%$379.1M$3.2B
#12
$1M12N/AN/AN/A
#13
$10.9M78N/AN/AN/A
#14
$196.8M1004N/AN/AN/A
#15
$59.7M341-19%N/AN/A
#16
$0.5M7N/AN/AN/A
#17
$74.9M4137%N/AN/A
#18
$2.2M22N/AN/AN/A
#19
$21.9M81N/AN/AN/A
#20
$11.5M825%$31.6MN/A
Add Company

What Is ZeOmega?

ZeOmegaâ??s powerful population health management platform delivers high-value, strategic solutions enabling payers and care-delivery organizations to improve individual health and provider performance. With deep domain expertise and a comprehensive understanding of complex population health challenges, ZeOmega serves as a â??true-northâ?? partner for clientsâ??offering flexible deployment and delivery models that leverage an innovative platform designed to integrate workflow, analytics, content and communication capabilities. By consistently meeting customer expectations and project benchmarks, ZeOmega has earned a sterling reputation in the industry for responsiveness and reliability. For more information, visit www.zeomega.com or call 214-618-9880. Follow ZeOmega on Twitter, LinkedIn or Facebook.

keywords:Biotechnology

$21.5M

Total Funding

656

Number of Employees

$120.8M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ZeOmega News

2022-04-20 - Care Management Solutions Market Size, Outlook And ...

TriZetto Corporation, Cerner Corporation, Epic Corporation Inc, ZeOmega Inc, Pegasystems Inc, TCS Healthcare Technologies, Salesforce.com, Medecision Inc,...

2022-04-20 - Accountable Care Solutions Market to See Huge Growth by ...

Accountable Care Solutions Market to See Huge Growth by 2027 | ZeOmega, eClinicalWorks, Verisk Health. Latest added Accountable Care Solutions Market research...

2022-04-17 - Chronic Diseases Management Market Size, Outlook And ...

... Pegasystems, AxisPoint Health, Wellcentive, Medecision, HealthSmart Holdings, Allscripts Healthcare Solutions, ZeOmega, Epic Corporation.

2021-08-17 - McLaren Integrated HMO Group Expands Its Relationship with ZeOmega

PLANO, Texas, Aug. 17, 2021 /PRNewswire/ -- McLaren Integrated HMO Group (MIG), headquartered in Flint, Michigan, has expanded its relationship with ZeOmega, the healthcare industry's leader for whole-person, population health management (PHM) solutions. MIG will use Jiva—ZeOmega's comprehensi ...

2021-02-23 - Community Care Plan Expands Relationship with ZeOmega® through Robust End-to-End Interoperability Solution

SUNRISE, Fla., Feb. 23, 2021 /PRNewswire/ -- Community Care Plan (CCP), a South Florida health plan serving 100,000 members, announced today that it has expanded its relationship with ZeOmega to deliver a new end-to-end Center for Medicare and Medicaid Services (CMS) interoperability solution. ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$165.6M65910%N/A
#2
$15M679-1%N/A
#3
$171.4M68214%N/A
#4
$131.3M70018%N/A
#5
$160.4M701-4%$34.7M